An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
| View More | |||||
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $95.43M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 33.5¢ | 33.0¢ | $90.83K | 275.0K |
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 93396 | 33.0¢ |
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 12634 | 2 |
| Last trade - 15.59pm 15/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |
ASX News
